Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, United States.
Clin Neurophysiol. 2011 May;122(5):1027-31. doi: 10.1016/j.clinph.2010.09.013. Epub 2010 Oct 12.
Cervical dystonia (CD) lacks an objective quantitative measure. Electrical impedance myography (EIM) is a non-invasive assessment method sensitive to changes in muscle structure and physiology. We evaluate the potential role of EIM in quantifying CD, hypothesizing that patients would demonstrate differences in the symmetry of muscle electrical resistance compared to controls, and that this asymmetry would decrease after botulinum neurotoxin (BoNT) treatment.
EIM was performed on the sternocleidomastoid (SCM) and cervical paraspinal (PS) muscles of CD patients and age-matched controls. 50 kHz resistance was analyzed, comparing side-to-side asymmetry in patients and controls, and, in patients, before and after BoNT treatment.
Sixteen patients and 10 controls were included. Resistance asymmetry was on average 3-5 times higher in patients than controls. Receiver operating characteristic analysis demonstrated 91% accuracy of discriminating CD from normal. From pre-treatment to maximum BoNT effect, asymmetry decreased from 20.8(13.9-26.1)% to 6.2(3.1-9.9)% (SCM), and from 16.0(14.3-16.0)% to 8.4(7.0-9.2)% (PS), p<0.05 (median, interquartile range).
EIM effectively differentiates normal subjects from CD patients by revealing asymmetries in resistance values and detects improvement in muscle symmetry after treatment.
These results suggest that EIM, a painless, non-invasive measure, can provide a useful quantitative metric in CD evaluation and deserves further study.
颈肌张力障碍 (CD) 缺乏客观的定量测量方法。电阻抗肌图 (EIM) 是一种非侵入性评估方法,对肌肉结构和生理学的变化敏感。我们评估 EIM 在定量 CD 中的潜在作用,假设患者的肌肉电阻对称性与对照组存在差异,并且这种不对称性在肉毒毒素 (BoNT) 治疗后会降低。
对 CD 患者和年龄匹配的对照组的胸锁乳突肌 (SCM) 和颈旁脊柱旁 (PS) 肌肉进行 EIM。分析 50 kHz 电阻,比较患者和对照组的侧-侧不对称性,并在患者中比较 BoNT 治疗前后的不对称性。
纳入了 16 名患者和 10 名对照者。与对照组相比,患者的电阻不对称性平均高出 3-5 倍。受试者工作特征分析表明,CD 与正常的区分准确率为 91%。从治疗前到最大 BoNT 效果,不对称性从 SCM 的 20.8(13.9-26.1)%降低到 6.2(3.1-9.9)%,PS 从 16.0(14.3-16.0)%降低到 8.4(7.0-9.2)%,p<0.05(中位数,四分位距)。
EIM 通过揭示阻力值的不对称性有效地区分正常受试者和 CD 患者,并检测治疗后肌肉对称性的改善。
这些结果表明,EIM 作为一种无痛、非侵入性的测量方法,可以为 CD 评估提供有用的定量指标,值得进一步研究。